Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Stockfleth

Showing results (91-100 of 152) with videos related to

Pageof 16
Sort By:
The Journal of Infectious Diseases|July 4, 1998
Association of rare human papillomavirus types with genital premalignant and malignant lesionsT Meyer, R Arndt, E Christophers, et al.
The British Journal of Dermatology|August 14, 2012
Potential impact of interventions resulting in reduced exposure to ultraviolet (UV) radiation (UVA and UVB) on skin cancer incidence in four European countries, 2010-2050E de Vries, M Arnold, E Altsitsiadis, et al.
The British Journal of Dermatology|May 15, 2008
A phase II dose-ranging study of topical resiquimod to treat actinic keratosisR-M Szeimies, J Bichel, J-P Ortonne, et al.
The British Journal of Dermatology|August 3, 2006
Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six casesC Ulrich, J O Busch, T Meyer, et al.
The British Journal of Dermatology|May 10, 2007
Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventionsM Trakatelli, C Ulrich, V del Marmol, et al.
The British Journal of Dermatology|October 15, 2017
Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalpE Stockfleth, C A Harwood, C Serra-Guillén, et al.
The British Journal of Dermatology|August 28, 2009
Polyphenon E: a new treatment for external anogenital wartsS Tatti, E Stockfleth, K R Beutner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 11, 2017
Actinic keratoses show variable histological basal growth patterns - a proposed classification adjustmentL Schmitz, T Gambichler, G Gupta, et al.
The British Journal of Dermatology|December 6, 2017
Response to 'Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp': reply from the authorsE Stockfleth, C A Harwood, C Serra-Guillén, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2019
Medical treatment of advanced cutaneous squamous-cell carcinomaF F Gellrich, S Hüning, S Beissert, et al.
Pageof 16

Showing results (91-100 of 152) with videos related to

Sort By:
Pageof 16
The Journal of Infectious Diseases|July 4, 1998
Association of rare human papillomavirus types with genital premalignant and malignant lesionsT Meyer, R Arndt, E Christophers, et al.
The British Journal of Dermatology|August 14, 2012
Potential impact of interventions resulting in reduced exposure to ultraviolet (UV) radiation (UVA and UVB) on skin cancer incidence in four European countries, 2010-2050E de Vries, M Arnold, E Altsitsiadis, et al.
The British Journal of Dermatology|May 15, 2008
A phase II dose-ranging study of topical resiquimod to treat actinic keratosisR-M Szeimies, J Bichel, J-P Ortonne, et al.
The British Journal of Dermatology|August 3, 2006
Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six casesC Ulrich, J O Busch, T Meyer, et al.
The British Journal of Dermatology|May 10, 2007
Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventionsM Trakatelli, C Ulrich, V del Marmol, et al.
The British Journal of Dermatology|October 15, 2017
Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalpE Stockfleth, C A Harwood, C Serra-Guillén, et al.
The British Journal of Dermatology|August 28, 2009
Polyphenon E: a new treatment for external anogenital wartsS Tatti, E Stockfleth, K R Beutner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 11, 2017
Actinic keratoses show variable histological basal growth patterns - a proposed classification adjustmentL Schmitz, T Gambichler, G Gupta, et al.
The British Journal of Dermatology|December 6, 2017
Response to 'Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp': reply from the authorsE Stockfleth, C A Harwood, C Serra-Guillén, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2019
Medical treatment of advanced cutaneous squamous-cell carcinomaF F Gellrich, S Hüning, S Beissert, et al.
Pageof 16